vs
Side-by-side financial comparison of RING ENERGY, INC. (REI) and Viridian Therapeutics, Inc.\DE (VRDN). Click either name above to swap in a different company.
Viridian Therapeutics, Inc.\DE is the larger business by last-quarter revenue ($70.6M vs $66.9M, roughly 1.1× RING ENERGY, INC.). On growth, Viridian Therapeutics, Inc.\DE posted the faster year-over-year revenue change (81958.1% vs -19.8%).
Siemens Energy AG is a German publicly traded energy corporation formed through the spin-off of the former Gas and Power division of Siemens, and it includes full ownership of Siemens Gamesa.
Viridian Therapeutics is a clinical-stage biotechnology firm developing novel disease-modifying therapies for rare, serious autoimmune and inflammatory diseases. Its lead pipeline candidate targets thyroid eye disease, a debilitating orbital disorder, with primary market focus on North America and Europe.
REI vs VRDN — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $66.9M | $70.6M |
| Net Profit | — | $-34.6M |
| Gross Margin | — | — |
| Operating Margin | -37.6% | -56.7% |
| Net Margin | — | -49.0% |
| Revenue YoY | -19.8% | 81958.1% |
| Net Profit YoY | — | 54.9% |
| EPS (diluted) | $-0.07 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $66.9M | — | ||
| Q3 25 | $78.6M | $70.6M | ||
| Q2 25 | $82.6M | — | ||
| Q1 25 | $79.1M | — | ||
| Q4 24 | $83.4M | — | ||
| Q3 24 | $89.2M | — | ||
| Q2 24 | $99.1M | — | ||
| Q1 24 | $94.5M | — |
| Q4 25 | — | — | ||
| Q3 25 | $-51.6M | $-34.6M | ||
| Q2 25 | $20.6M | — | ||
| Q1 25 | $9.1M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $33.9M | — | ||
| Q2 24 | $22.4M | — | ||
| Q1 24 | $5.5M | — |
| Q4 25 | -37.6% | — | ||
| Q3 25 | -70.0% | -56.7% | ||
| Q2 25 | 28.4% | — | ||
| Q1 25 | 28.3% | — | ||
| Q4 24 | 28.3% | — | ||
| Q3 24 | 33.4% | — | ||
| Q2 24 | 42.2% | — | ||
| Q1 24 | 39.8% | — |
| Q4 25 | — | — | ||
| Q3 25 | -65.7% | -49.0% | ||
| Q2 25 | 25.0% | — | ||
| Q1 25 | 11.5% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 38.0% | — | ||
| Q2 24 | 22.6% | — | ||
| Q1 24 | 5.8% | — |
| Q4 25 | $-0.07 | — | ||
| Q3 25 | $-0.25 | — | ||
| Q2 25 | $0.10 | — | ||
| Q1 25 | $0.05 | — | ||
| Q4 24 | $0.03 | — | ||
| Q3 24 | $0.17 | — | ||
| Q2 24 | $0.11 | — | ||
| Q1 24 | $0.03 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $902.9K | $490.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $836.3M | $503.0M |
| Total Assets | $1.4B | $577.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $902.9K | — | ||
| Q3 25 | $286.9K | $490.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | $1.1M | — | ||
| Q4 24 | $1.9M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $1.2M | — | ||
| Q1 24 | $1.4M | — |
| Q4 25 | $836.3M | — | ||
| Q3 25 | $847.7M | $503.0M | ||
| Q2 25 | $897.9M | — | ||
| Q1 25 | $876.0M | — | ||
| Q4 24 | $858.6M | — | ||
| Q3 24 | $851.3M | — | ||
| Q2 24 | $817.4M | — | ||
| Q1 24 | $793.0M | — |
| Q4 25 | $1.4B | — | ||
| Q3 25 | $1.4B | $577.1M | ||
| Q2 25 | $1.5B | — | ||
| Q1 25 | $1.5B | — | ||
| Q4 24 | $1.4B | — | ||
| Q3 24 | $1.4B | — | ||
| Q2 24 | $1.4B | — | ||
| Q1 24 | $1.4B | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $44.7M | $-84.6M |
| Free Cash FlowOCF − Capex | — | $-84.7M |
| FCF MarginFCF / Revenue | — | -120.1% |
| Capex IntensityCapex / Revenue | — | 0.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $44.7M | — | ||
| Q3 25 | $44.5M | $-84.6M | ||
| Q2 25 | $33.3M | — | ||
| Q1 25 | $28.4M | — | ||
| Q4 24 | $47.3M | — | ||
| Q3 24 | $51.3M | — | ||
| Q2 24 | $50.6M | — | ||
| Q1 24 | $45.2M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | $-84.7M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | -120.1% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.2% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 1.61× | — | ||
| Q1 25 | 3.11× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.52× | — | ||
| Q2 24 | 2.26× | — | ||
| Q1 24 | 8.19× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
